Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003594053 | SCV001060690 | likely benign | Rubinstein-Taybi syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495518 | SCV002801040 | likely benign | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2022-01-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003978002 | SCV004795047 | likely benign | CREBBP-related disorder | 2022-05-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |